Challenges faced in transfering economic evaluations to middle income countries Ver más »
Althabe F. et al. Zika virus and microcephaly: why is this situation a PHEIC?. The Lancet. Volume 387, No. 10020, p719–721, 20 February 2016.
Zika virus and microcephaly: why is this situation a PHEIC? Ver más »
Mazzoni A, Althabe F, Gutierrez L, Gibbons L, Liu NH, Bonotti AM, Izbizky GH, Ferrary M, Viergue N, Vigil SI, Zalazar Denett G, Belizán JM.BMC Pregnancy Childbirth. Women's preferences and mode of delivery in public and private hospitals: a prospective cohort study.
2016 Feb 8;16(1):34. doi: 10.1186/s12884-016-0824-0.
Pichon-Riviere A, Alcaraz A, Caporale J, Bardach A, Rey-Ares L, Klein K, Calderón M, Augustovski F, Tatti S. Costo-efectividad de la vacuna tetravalente contra VPH en Argentina, a partir de un modelo dinámico de transmisión [Cost-effectiveness of quadrivalent vaccine against human papilloma virus in Argentina based on a dynamic transmission model]. Salud Publica Mex. 2015 Nov-Dec;57(6):504-13. Spanish. PMID: 26679313.
A. Rubinstein,N. Elorriaga,O. U. Garay,R. Poggio,J. Caporale,M. G. Matta,F. Augustovski,A. Pichon-Riviere and D. Mozaffarian. Eliminating artificial trans fatty acids in Argentina: estimated effects on the burden of coronary heart disease and costs. Bull World Health Organ. 2015;93(9):10.2471/blt.14.150516.
A. Pichon-Riviere,D. Glujovsky,O. U. Garay,F. Augustovski,A. Ciapponi,M. Serpa and F. Althabe. Correction: Oxytocin in Uniject Disposable Auto-Disable Injection System versus Standard Use for the Prevention of Postpartum Hemorrhage in Latin America and the Caribbean: A Cost-Effectiveness Analysis. PLoS One. 2015;10(7):10.1371/journal.pone.0133344.
Pichon-Riviere, Andrés & Augustovski, Federico & Garcia Marti, Sebastian & Caporale, Joaquín. (2015). The Efficiency Path: An Estimation of Cost-Effectiveness Thresholds for 185 Countries Based on Per Capita Health Expenditures and Life Expectancy. Value in Health. 18. A695-A696. 10.1016/j.jval.2015.09.2592.
D. Peiris,S. R. Thompson,A. Beratarrechea,M. K. Cárdenas,F. Diez-Canseco,J. Goudge,J. Gyamfi,J. H. Kamano,V. Irazola,C. Johnson,A. P. Kengne,N. K. Keat,J. J. Miranda,S. Mohan,B. Mukasa,E. Ng,R. Nieuwlaat,O. Ogedegbe,B. Ovbiagele,J. Plange-Rhule,D. Praveen,A. Salam,M. Thorogood,A. G. Thrift,R. Vedanthan,S. P. Waddy,J. Webster,R. Webster,K. Yeates and K. Yusoff. Behaviour change strategies for reducing blood pressure-related disease burden: findings from a global implementation research programme. Implement Sci. 2015;10:10.1186/s13012-015-0331-0.
Husereau D, Drummond M, Petrou S, et al. Reply to Roberts et al.: CHEERS is Sufficient for Reporting Cost-Benefit Analysis, but May Require Further Elaboration. PharmacoEconomics. May 2015;33(5):535-536,
G. J. Hofmeyr,A. H. Seuc,A. P. Betran,T. D. Purnat,A. Ciganda,S. P. Munjanja,S. Manyame,M. Singata,S. Fawcus,K. Frank,D. R. Hall,G. Cormick,J. M. Roberts,E. F. Bergel,S. K. Drebit,P. Von Dadelszen,J. M. Belizan and G. Calcium Pre-Eclampsia Study. The effect of calcium supplementation on blood pressure in non-pregnant women with previous pre-eclampsia: An exploratory, randomized placebo controlled study. Pregnancy Hypertension-an International Journal of Womens Cardiovascular Health. 2015;5(4):10.1016/j.preghy.2015.04.001.
